Saturday 17 October 2026
Export DXR’s income statement to Excel — free account
Daxor Corporation
DXR Healthcare Medical Instruments & Supplies
Revenue growth for five consecutive years.
10.05
0.15
−1.47%
Follow DXR
Daxor Corporation (DXR) P/E ratio
As of 16 October 2026, Daxor Corporation (DXR) trades at a P/E ratio of 4.7×. Over the past ten years it has ranged from 0.0× (December 2021) to 18.3× (June 2022); the current reading is higher than 82% of that period. That is below the Medical Instruments & Supplies industry median of 33.8× and below the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2022 | 3.7× | (76.57%) |
| FY2021 | 15.7× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
| FY2015 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2023 | 4.5× | 21.55% |
| Dec 2022 | 3.7× | (66.88%) |
| Jun 2022 | 11.1× | (29.26%) |
| Dec 2021 | 15.7× | — |
| 7 more quarters | Free account |
Against its own ten years
Low 0.0×
High 18.3×
Ten-year median
0.0×
Current reading's percentile
56
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| STXS Stereotaxis Inc. compare | n/m |
| MBOT Microbot Medical Inc. compare | n/m |
| POCI Precision Optics Corp. compare | n/m |
| NYXH Nyxoah SA compare | n/m |
| MLSS Milestone Scientific, Inc. compare | n/m |
| HBIO Harvard Bioscience, Inc. compare | n/m |
| ZTEKF Zentek Ltd. compare | n/m |
| DXR Daxor Corporation | 4.7× |
| NEPH Nephros Inc. compare | 23.4× |
| Medical Instruments & Supplies industry median | 33.8× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)